Is adjuvant chemotherapy worthwhile after radical resection for single lung metastasis from colorectal cancer? A multicentric analysis evaluating the risk of recurrence

Cristian Rapicetta, Filippo Lococo, Federico Davini, Francesco Carleo, Juha Kauppi, Teresa Severina Di Stefano, Sara Ricciardi, Marco Di Martino, Jari Räsänen, Massimiliano Paci, Franca Melfi, Giuseppe Cardillo

Research output: Contribution to journalArticle

Abstract

Background: Adjuvant chemotherapy after resection of colorectal cancer (CRC) lung metastases may reduce recurrences and improve survival. The choice of best candidates for adjuvant chemotherapy in this setting is controversial, especially when a single lung metastases (SLM) is resected. The aim of this study is to evaluate the risk of recurrence after radical resection for single lung metastasis from CRC. Patients and methods: Demographic, clinical, and pathological data were retrospectively collected for patients radically operated on for single pulmonary metastasis from CRC in 4 centers. Survival was computed by Kaplan-Meyer methods. Chi-square, log-rank test, and for multivariate analysis, Cox-regression and binary logistic regression were used when indicated. Results: The sample consisted of 344 patients, mean age 65 yrs. Overall 5 yrs survival was 61.9%. Recurrence occurred in 113 pts (32.8%). At univariate analysis, age > 70 (p = 0.046) and tumor size > 2 cm (p = 0.038) were predictive of the worst survival chance, while synchronous lung metastasis (p = 0.039), previous resection of extrathoracic metastasis (p = 0.017), uptake at FDG-PET scan (p = 0.006) and short (<12 months) disease-free interval (DFI) prior to lung metastasectomy (p = 0.048) were risk factors for recurrence. At multivariate analysis, only high CEA (>4 ng/mL) was associated with worst survival (HR: 4.3, p = 0.014), while prior abdominal surgery (HR: 3, p = 0.033), PET positivity (HR: 2.7, p = 0.041), and DFI > 12 months (HR: 0.14, p < 0.001) confirmed to predict recurrence of disease. Conclusions: Surgical resection of solitary lung metastases from CRC is associated with prolonged survival. High value of CEA, PET positivity, previous extrathoracic resected metastasis, and short (<12 months) DFI were found to be predictive of death or disease recurrence and might identify in this scenario patients at higher risk which could potential benefit of chemotherapy.

Original languageEnglish
Article number763
JournalFrontiers in Oncology
Volume9
Issue numberAUG
DOIs
Publication statusPublished - Jan 1 2019

Fingerprint

Adjuvant Chemotherapy
Colorectal Neoplasms
Neoplasm Metastasis
Recurrence
Lung
Survival
Positron-Emission Tomography
Lung Neoplasms
Multivariate Analysis
Logistic Models
Demography
Drug Therapy
Neoplasms

Keywords

  • CEA
  • Colorectal cancer
  • Metastasis
  • Recurrence
  • Survival

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Is adjuvant chemotherapy worthwhile after radical resection for single lung metastasis from colorectal cancer? A multicentric analysis evaluating the risk of recurrence. / Rapicetta, Cristian; Lococo, Filippo; Davini, Federico; Carleo, Francesco; Kauppi, Juha; Di Stefano, Teresa Severina; Ricciardi, Sara; Di Martino, Marco; Räsänen, Jari; Paci, Massimiliano; Melfi, Franca; Cardillo, Giuseppe.

In: Frontiers in Oncology, Vol. 9, No. AUG, 763, 01.01.2019.

Research output: Contribution to journalArticle

Rapicetta, Cristian ; Lococo, Filippo ; Davini, Federico ; Carleo, Francesco ; Kauppi, Juha ; Di Stefano, Teresa Severina ; Ricciardi, Sara ; Di Martino, Marco ; Räsänen, Jari ; Paci, Massimiliano ; Melfi, Franca ; Cardillo, Giuseppe. / Is adjuvant chemotherapy worthwhile after radical resection for single lung metastasis from colorectal cancer? A multicentric analysis evaluating the risk of recurrence. In: Frontiers in Oncology. 2019 ; Vol. 9, No. AUG.
@article{94cc1849ec764b58ba59b2897f361198,
title = "Is adjuvant chemotherapy worthwhile after radical resection for single lung metastasis from colorectal cancer? A multicentric analysis evaluating the risk of recurrence",
abstract = "Background: Adjuvant chemotherapy after resection of colorectal cancer (CRC) lung metastases may reduce recurrences and improve survival. The choice of best candidates for adjuvant chemotherapy in this setting is controversial, especially when a single lung metastases (SLM) is resected. The aim of this study is to evaluate the risk of recurrence after radical resection for single lung metastasis from CRC. Patients and methods: Demographic, clinical, and pathological data were retrospectively collected for patients radically operated on for single pulmonary metastasis from CRC in 4 centers. Survival was computed by Kaplan-Meyer methods. Chi-square, log-rank test, and for multivariate analysis, Cox-regression and binary logistic regression were used when indicated. Results: The sample consisted of 344 patients, mean age 65 yrs. Overall 5 yrs survival was 61.9{\%}. Recurrence occurred in 113 pts (32.8{\%}). At univariate analysis, age > 70 (p = 0.046) and tumor size > 2 cm (p = 0.038) were predictive of the worst survival chance, while synchronous lung metastasis (p = 0.039), previous resection of extrathoracic metastasis (p = 0.017), uptake at FDG-PET scan (p = 0.006) and short (<12 months) disease-free interval (DFI) prior to lung metastasectomy (p = 0.048) were risk factors for recurrence. At multivariate analysis, only high CEA (>4 ng/mL) was associated with worst survival (HR: 4.3, p = 0.014), while prior abdominal surgery (HR: 3, p = 0.033), PET positivity (HR: 2.7, p = 0.041), and DFI > 12 months (HR: 0.14, p < 0.001) confirmed to predict recurrence of disease. Conclusions: Surgical resection of solitary lung metastases from CRC is associated with prolonged survival. High value of CEA, PET positivity, previous extrathoracic resected metastasis, and short (<12 months) DFI were found to be predictive of death or disease recurrence and might identify in this scenario patients at higher risk which could potential benefit of chemotherapy.",
keywords = "CEA, Colorectal cancer, Metastasis, Recurrence, Survival",
author = "Cristian Rapicetta and Filippo Lococo and Federico Davini and Francesco Carleo and Juha Kauppi and {Di Stefano}, {Teresa Severina} and Sara Ricciardi and {Di Martino}, Marco and Jari R{\"a}s{\"a}nen and Massimiliano Paci and Franca Melfi and Giuseppe Cardillo",
year = "2019",
month = "1",
day = "1",
doi = "10.3389/fonc.2019.00763",
language = "English",
volume = "9",
journal = "Frontiers in Oncology",
issn = "2234-943X",
publisher = "Frontiers Media S. A.",
number = "AUG",

}

TY - JOUR

T1 - Is adjuvant chemotherapy worthwhile after radical resection for single lung metastasis from colorectal cancer? A multicentric analysis evaluating the risk of recurrence

AU - Rapicetta, Cristian

AU - Lococo, Filippo

AU - Davini, Federico

AU - Carleo, Francesco

AU - Kauppi, Juha

AU - Di Stefano, Teresa Severina

AU - Ricciardi, Sara

AU - Di Martino, Marco

AU - Räsänen, Jari

AU - Paci, Massimiliano

AU - Melfi, Franca

AU - Cardillo, Giuseppe

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Background: Adjuvant chemotherapy after resection of colorectal cancer (CRC) lung metastases may reduce recurrences and improve survival. The choice of best candidates for adjuvant chemotherapy in this setting is controversial, especially when a single lung metastases (SLM) is resected. The aim of this study is to evaluate the risk of recurrence after radical resection for single lung metastasis from CRC. Patients and methods: Demographic, clinical, and pathological data were retrospectively collected for patients radically operated on for single pulmonary metastasis from CRC in 4 centers. Survival was computed by Kaplan-Meyer methods. Chi-square, log-rank test, and for multivariate analysis, Cox-regression and binary logistic regression were used when indicated. Results: The sample consisted of 344 patients, mean age 65 yrs. Overall 5 yrs survival was 61.9%. Recurrence occurred in 113 pts (32.8%). At univariate analysis, age > 70 (p = 0.046) and tumor size > 2 cm (p = 0.038) were predictive of the worst survival chance, while synchronous lung metastasis (p = 0.039), previous resection of extrathoracic metastasis (p = 0.017), uptake at FDG-PET scan (p = 0.006) and short (<12 months) disease-free interval (DFI) prior to lung metastasectomy (p = 0.048) were risk factors for recurrence. At multivariate analysis, only high CEA (>4 ng/mL) was associated with worst survival (HR: 4.3, p = 0.014), while prior abdominal surgery (HR: 3, p = 0.033), PET positivity (HR: 2.7, p = 0.041), and DFI > 12 months (HR: 0.14, p < 0.001) confirmed to predict recurrence of disease. Conclusions: Surgical resection of solitary lung metastases from CRC is associated with prolonged survival. High value of CEA, PET positivity, previous extrathoracic resected metastasis, and short (<12 months) DFI were found to be predictive of death or disease recurrence and might identify in this scenario patients at higher risk which could potential benefit of chemotherapy.

AB - Background: Adjuvant chemotherapy after resection of colorectal cancer (CRC) lung metastases may reduce recurrences and improve survival. The choice of best candidates for adjuvant chemotherapy in this setting is controversial, especially when a single lung metastases (SLM) is resected. The aim of this study is to evaluate the risk of recurrence after radical resection for single lung metastasis from CRC. Patients and methods: Demographic, clinical, and pathological data were retrospectively collected for patients radically operated on for single pulmonary metastasis from CRC in 4 centers. Survival was computed by Kaplan-Meyer methods. Chi-square, log-rank test, and for multivariate analysis, Cox-regression and binary logistic regression were used when indicated. Results: The sample consisted of 344 patients, mean age 65 yrs. Overall 5 yrs survival was 61.9%. Recurrence occurred in 113 pts (32.8%). At univariate analysis, age > 70 (p = 0.046) and tumor size > 2 cm (p = 0.038) were predictive of the worst survival chance, while synchronous lung metastasis (p = 0.039), previous resection of extrathoracic metastasis (p = 0.017), uptake at FDG-PET scan (p = 0.006) and short (<12 months) disease-free interval (DFI) prior to lung metastasectomy (p = 0.048) were risk factors for recurrence. At multivariate analysis, only high CEA (>4 ng/mL) was associated with worst survival (HR: 4.3, p = 0.014), while prior abdominal surgery (HR: 3, p = 0.033), PET positivity (HR: 2.7, p = 0.041), and DFI > 12 months (HR: 0.14, p < 0.001) confirmed to predict recurrence of disease. Conclusions: Surgical resection of solitary lung metastases from CRC is associated with prolonged survival. High value of CEA, PET positivity, previous extrathoracic resected metastasis, and short (<12 months) DFI were found to be predictive of death or disease recurrence and might identify in this scenario patients at higher risk which could potential benefit of chemotherapy.

KW - CEA

KW - Colorectal cancer

KW - Metastasis

KW - Recurrence

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=85071677002&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071677002&partnerID=8YFLogxK

U2 - 10.3389/fonc.2019.00763

DO - 10.3389/fonc.2019.00763

M3 - Article

AN - SCOPUS:85071677002

VL - 9

JO - Frontiers in Oncology

JF - Frontiers in Oncology

SN - 2234-943X

IS - AUG

M1 - 763

ER -